CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale See Remarks sold 165 shares at $2.62 ($432)
- 4 Planned sale CEO and President sold 5,268 shares at an average $2.62 ($13,823)
- 4 Planned sale Chief Financial Officer sold 1,069 shares at $2.64 ($2,817)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,008 shares at $2.64 ($2,656)
- 4 Planned sale See Remarks sold 1,012 shares at $2.64 ($2,667)
- 4 Planned sale Chief Scientific Officer sold 1,067 shares at $2.64 ($2,812)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-K Report Annual Report
Page 13 of 34 · 672 filings